The NeoDeco Study
Research type
Research Study
Full title
Optimising kangaroo care to reduce neonatal severe infection/sepsis and resistant bacterial colonisation among high-risk infants in neonatal intensive care: a pragmatic, multicentre, parallel cluster randomised hybrid implementation-effectiveness trial (NeoDeco)
IRAS ID
331038
Contact name
Jennifer Martin
Contact email
Sponsor organisation
Penta Foundation (Penta)
Clinicaltrials.gov Identifier
Duration of Study in the UK
1 years, 4 months, 31 days
Research summary
Skin to skin contact (StSC) between an infant and carer has several beneficial effects. Early, regular and prolonged StSC as a unit-level strategy may decrease the risk of resistant bacterial colonisation in infants receiving neonatal intensive care, but this has not been investigated in a robust manner to date. When applied for its potential infection prevention and control (IPC) effects, it may therefore be beneficial to provide StSC to a wider range of infants than the preterm infants usually targeted. We aim to investigate such a strategy in the NeoDeco trial.
The NeoDeco Study is looking at optimising the practice of StSC contact between premature babies and their careers in neonatal care units. The Study will look at the impact the optimised practice of StSC contact may have on neonatal infection and sepsis occurrences, and the presence of harmful bacteria in infants admitted to Neonatal units. NeoDeco is a multi-centre trial, with 24 hospital (Neonatal Units) sites from 5 countries .
NeoDeco is pragmatic, multicentre, parallel cluster randomised hybrid implementation-effectiveness Study. The Study will last a total of 17 months including a baseline, wash-in and intervention Period.REC name
London - Dulwich Research Ethics Committee
REC reference
24/HRA/1952
Date of REC Opinion
4 Jul 2024
REC opinion
Further Information Favourable Opinion